Beam Therapeutics Inc.
BEAM
31 insider filings · Latest: Jun 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 1 8:05 PM | John M. EvansDirector, CEO | Sale | 25,000 | $34.31 | $857.7K | 1,047,205(D) | View → |
| Jun 29, 2026 | Jul 1 8:05 PM | John M. EvansDirector, CEO | Sale | 25,000 | $35.49 | $887.4K | 1,047,205(D) | View → |
| Jun 30, 2026 | Jun 30 8:19 PM | JOHN M EVANS | Proposed Sale | 25,000 | $34.31 | $857.7K | — | View → |
| Jun 29, 2026 | Jun 29 8:14 PM | JOHN M EVANS | Proposed Sale | 25,000 | $35.49 | $887.4K | — | View → |
| Jun 26, 2026 | Jun 29 6:17 PM | FMR LLC10% Owner, Other | Sale | 251,488 | $35.26 | $8.9M | 854,583(I) | View → |
| Jun 25, 2026 | Jun 29 6:17 PM | FMR LLC10% Owner, Other | Sale | 33,372 | $35.12 | $1.2M | 1,106,071(I) | View → |
| Apr 14, 2026 | Apr 14 8:28 PM | CAROLE HO | Proposed Sale | 87,784 | $30.73 | $2.7M | — | View → |
| Apr 1, 2026 | Apr 6 9:48 PM | John M. EvansDirector, CEO | Sale | 30,078 | $24.58 | $739.3K | 1,047,205(D) | View → |
| Apr 1, 2026 | Apr 6 9:44 PM | Amy SimonChief Medical Officer | Sale | 6,700 | $24.58 | $164.7K | 102,735(D) | View → |
| Apr 1, 2026 | Apr 6 9:39 PM | Bethany J CavanaghSVP, Finance and Treasurer | Sale | 3,242 | $24.58 | $79.7K | 51,171(D) | View → |
| Apr 1, 2026 | Apr 6 9:39 PM | Christine BellonChief Legal Officer | Sale | 5,956 | $24.58 | $146.4K | 109,711(D) | View → |
| Apr 1, 2026 | Apr 6 9:34 PM | Giuseppe CiaramellaPresident | Sale | 11,810 | $24.58 | $290.3K | 218,406(D) | View → |
| Mar 31, 2026 | Apr 1 10:32 PM | John M. EvansDirector, CEO | Sale | 25,000 | $22.76 | $569.1K | 986,667(D) | View → |
| Mar 30, 2026 | Apr 1 10:32 PM | John M. EvansDirector, CEO | Sale | 25,000 | $22.37 | $559.2K | 986,667(D) | View → |
| Apr 2, 2026 | Mar 31 8:33 PM | CHRISTINE BELLON | Proposed Sale | 20,000 | $21.90 | $438.0K | — | View → |
| Apr 2, 2026 | Mar 31 8:29 PM | GIUSEPPE CIARAMELLA | Proposed Sale | 26,250 | $21.90 | $574.9K | — | View → |
| Apr 2, 2026 | Mar 31 8:22 PM | AMY SIMON | Proposed Sale | 20,000 | $21.90 | $438.0K | — | View → |
| Apr 2, 2026 | Mar 31 8:19 PM | JOHN M. EVANS | Proposed Sale | 66,874 | $21.90 | $1.5M | — | View → |
| Mar 31, 2026 | Mar 31 8:16 PM | JOHN M EVANS | Proposed Sale | 25,000 | $22.76 | $569.1K | — | View → |
| Mar 30, 2026 | Mar 30 9:28 PM | JOHN M EVANS | Proposed Sale | 25,000 | $22.37 | $559.2K | — | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 1 8:05 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $1.03 | 205,804(D) | View → |
| Jun 29, 2026 | Jul 1 8:05 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $1.03 | 230,804(D) | View → |
| Jun 17, 2026 | Jun 22 8:05 PM | Giuseppe CiaramellaPresident | Option Exercise | 35,505 | $1.03 | 56,946(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Christi ShawDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Kathleen E WalshDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | John MaraganoreDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Mark FishmanDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Chirfi GuindoDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Graham K CooperDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Mar 31, 2026 | Apr 1 10:32 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $0.67 | 18,672(D) | View → |
| Mar 30, 2026 | Apr 1 10:32 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $0.67 | 43,672(D) | View → |
| Feb 24, 2026 | Feb 26 9:05 PM | Giuseppe CiaramellaPresident | Option Exercise | 35,000 | $17.00 | 397,313(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Bethany J CavanaghSVP, Finance and Treasurer | Grant/Award | 40,000 | $27.62 | 40,000(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Giuseppe CiaramellaPresident | Grant/Award | 80,000 | $27.62 | 80,000(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Sravan Kumar EmanyChief Financial Officer | Grant/Award | 63,500 | $27.62 | 63,500(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Christine BellonChief Legal Officer | Grant/Award | 40,000 | $27.62 | 40,000(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Grant/Award | 180,000 | $27.62 | 180,000(D) | View → |
| Jan 30, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $0.67 | 68,672(D) | View → |
| Jan 29, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $0.67 | 93,672(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Amy SimonChief Medical Officer | Grant/Award | 88,500 | $27.62 | 88,500(D) | View → |